Seres Therapeutics, Inc. (MCRB) Operating income 2016–2025
Seres Therapeutics, Inc. (MCRB) annual operating income history from SEC filings — each fiscal year as reported.
-$94.0MFY2025 · since FY2016: -$92.8M → -$94.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$94.0M | +22.5% |
| FY2024 | -$121.3M | +37.8% |
| FY2023 | -$195.1M | -8.4% |
| FY2022 | -$179.9M | -179.0% |
| FY2021 | -$64.5M | +26.8% |
| FY2020 | -$88.1M | -22.6% |
| FY2019 | -$71.9M | +28.3% |
| FY2018 | -$100.3M | -9.7% |
| FY2017 | -$91.4M | +1.6% |
| FY2016 | -$92.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice